-
Mashup Score: 4
prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), Metastatic Hormone-sensitive Prostate Cancer Treatment, Docetaxel, Novel Hormonal Therapy (NHT), enzalutamide, apalutamide, abiraterone, androgen deprivation therapy (ADT).
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4
prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), Metastatic Hormone-sensitive Prostate Cancer Treatment, Docetaxel, Novel Hormonal Therapy (NHT), enzalutamide, apalutamide, abiraterone, androgen deprivation therapy (ADT).
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4
prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), Metastatic Hormone-sensitive Prostate Cancer Treatment, Docetaxel, Novel Hormonal Therapy (NHT), enzalutamide, apalutamide, abiraterone, androgen deprivation therapy (ADT).
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Germline genetic testing, somatic tumor testing, prostate cancer, Metastatic Hormone Sensitive Prostate Cancer (mHSPC), PSMA-PET imaging Ga-68, F-18 pifluofolastat PSMA, cytoreductive prostatectomy, docetaxel doublet therapy, docetaxel triplet therapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 6
Germline genetic testing, somatic tumor testing, prostate cancer, Metastatic Hormone Sensitive Prostate Cancer (mHSPC), PSMA-PET imaging Ga-68, F-18 pifluofolastat PSMA, cytoreductive prostatectomy, docetaxel doublet therapy, docetaxel triplet therapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 5
Germline genetic testing, somatic tumor testing, prostate cancer, Metastatic Hormone Sensitive Prostate Cancer (mHSPC), PSMA-PET imaging Ga-68, F-18 pifluofolastat PSMA, cytoreductive prostatectomy, docetaxel doublet therapy, docetaxel triplet therapy.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
Does research from clinical trials in #mHSPC treatment translate into access to treatments for patients in the "Real World"? #BeyondTheAbstract with @JoannaDodkins on UroToday > https://t.co/ojTe7PJ8Z3 @EurUrolOncol https://t.co/O0mQwHN3AP